Azitra Inc (AZTR)
PHARMACEUTICAL PREPARATIONS
Azitra Inc (AZTR) is listed on NYSE American, where it has traded since June 16, 2023.
- Listed On
- NYSE American
- Listed Since
- June 16, 2023
- Employees
- 13
- Market Cap
- $10M
About Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 14 institutions reported holding AZTR, with 19.4 million shares worth $3.3 million in aggregate. The largest reported holder was Dauntless Investment Group, with 11.3 million shares worth $1.9 million. Of the 5 largest holders listed below, 3 opened new positions in AZTR, 1 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Dauntless Investment Group | 11,292,186 | $2M | Added 1129118.6% |
| Stonepine Capital Management | 5,285,476 | $887K | New position |
| Nantahala Capital Management | 2,213,613 | $371K | New position |
| Jane Street Group | 248,433 | $42K | New position |
| Geode Capital Management | 95,409 | $16K | Reduced 79.69% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is AZTR?
Azitra Inc (AZTR) is listed on NYSE American, where it has traded since June 16, 2023.
Who are the largest institutional holders of AZTR?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of AZTR were Dauntless Investment Group, Stonepine Capital Management and Nantahala Capital Management.
How many institutions own AZTR?
14 institutions reported a position in AZTR for the quarter ended June 30, 2026, worth $3.3 million in total.
Did institutions buy or sell AZTR last quarter?
Of the 5 largest reported holders, 3 opened new positions in AZTR, 1 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for AZTR.
Every reported institutional holder, plus insider and congressional trades in AZTR, on SentiSense.